Where to Draw the Line on Gene-Editing Technology
New techniques that could make germ-line genetic engineering unprecedentedly easy are forcing policy makers to confront the ethical implications of moving forward
Where to Draw the Line on Gene-Editing Technology
New techniques that could make germ-line genetic engineering unprecedentedly easy are forcing policy makers to confront the ethical implications of moving forward
Genome Editing: 7 Facts About a Revolutionary Technology
What everyone should know about cut-and-paste genetics
'Gene Drive' Mosquitoes Engineered to Fight Malaria
Mutant mozzies could rapidly spread through wild populations
Vocal Cords Bioengineered from Starter Cells
Researchers took cells from donated vocal cord tissue and successfully grew them on a three-dimensional scaffold to produce new vocal cords that can produce sound
Researchers Grow Vocal Cord Tissue That Can "Talk"
The tissue engineering technique could someday help restore the voices of patients with otherwise untreatable vocal disorders, although more testing must be done
Baby's Experimental Leukemia Treatment Could Help Others with Cancer
New gene-editing technology that successfully reprogrammed cells to fight leukemia in a 14-weeks-old infant could be applied to other cancers
Unsupervised, Mobile and Wireless Brain–Computer Interfaces on the Horizon
Researchers are working to engineer practical devices that patients can use in their homes
U.S. Deaths Drop for Leading Causes
Fatalities from causes like heart disease, cancer and stroke dropped 43 percent between 1969 and 2013
New Medical Devices Vanish Inside You
Implants that prop open clogged arteries and then dissolve are part of a new medical frontier
2 Companies Seek FDA Approval for Brain Games to Treat ADHD
Interactive games show some success in small, preliminary studies, but scientists have reservations
Neuron Transplants May One Day Reverse Blindness
Scientists restored youthful brain plasticity and vision in mice
Why Biomedical Superstars Are Signing On with Google
Tech firm’s ambitious goals and abundant resources attract life scientists, most recently Harvard Medical School cardiologist Jessica Mega